{"id":434725,"date":"2026-11-09T09:27:00","date_gmt":"2026-11-09T09:27:00","guid":{"rendered":"https:\/\/dailybanglanewspapers.com\/news\/nxeras-president-ceo-to-participate-in-a-fireside-chat-at-the-jefferies-london-healthcare-conference-2026\/"},"modified":"2026-11-09T09:27:00","modified_gmt":"2026-11-09T09:27:00","slug":"nxeras-president-ceo-to-participate-in-a-fireside-chat-at-the-jefferies-london-healthcare-conference-2026","status":"publish","type":"post","link":"https:\/\/dailybanglanewspapers.com\/news\/nxeras-president-ceo-to-participate-in-a-fireside-chat-at-the-jefferies-london-healthcare-conference-2026\/","title":{"rendered":"Nxera\u2019s President &#038; CEO to Participate in a \u2018Fireside Chat\u2019 at the Jefferies London Healthcare Conference 2026"},"content":{"rendered":"<p><\/p>\n<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p>Tokyo, Japan and Cambridge, UK, 9 November 2026 \u2013 Nxera Pharma Co., Ltd. (\u201cNxera\u201d or \u201cthe Company\u201d; TSE 4565) announces its President &amp; CEO, Chris Cargill, will participate in a \u2018Fireside Chat\u2019 at the Jefferies London Healthcare Conference on Monday,16th November at 4:30 p.m. GMT \/ 17th 1:30 a.m. JST. During the event, Mr. Cargill will present the Company\u2019s strategy, recent progress and expected upcoming milestones to leading global life sciences investors.<\/p>\n<p>The live webcast of the \u2018Fireside Chat\u2019 will be available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=phDjJnYlkpb0YajuK2YyD_AQYb397neiUpvf4fneOn9pnZgCK3BzpdlPZ50JyIY6M1dffoUlcEBKqnFlYpk0P478gcB7OkrEb_E5G8r6p9z2TL3x-4B6T0RsMjoyC-B3cuilQRY6nd-h7sAXZ7_mHA==\" rel=\"nofollow\" target=\"_blank\" title=\"here\">here<\/a>.<\/p>\n<p>The replay will also be available at the same link for 90 days post the event.<\/p>\n<p align=\"center\" style=\"text-align:center;\">\u2013END\u2013<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><b>About Nxera Pharma<\/b><br \/>Nxera Pharma is a technology powered biopharma company in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. The Company has built an agile, new-generation commercial business in Japan to develop and commercialize innovative medicines, including several launched products, to address this high-value, large and growing market and those in the broader APAC region. In addition, the Company is advancing an extensive pipeline internally and in partnership with leading pharma and biotech companies powered by its unique NxWave\u2122 GPCR structure-based drug discovery platform. Nxera Pharma operates at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland) and Seoul (South Korea) and is listed on the Tokyo Stock Exchange (ticker: 4565).<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L1XBHmD6vSTIeSr6ljj5mhkhoQtYtcn3X5AUNorsFkmXaA3yAZq70JgbeIhS7WSglA7wNWof0aVOSl69iOM2PA==\" rel=\"nofollow\" target=\"_blank\" title=\"www.nxera.life\">www.nxera.life<\/a><br \/>LinkedIn: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lRxeCMXPo7q5nGEjaAnntctFbmuhA7OTrn3yKsMiKBrsRxq6v7kK8GhuAeX9hNj73vnREFm3o5pQ4rRLZsNIveQfxjCTTe4-cLZ-7RvQMPNU_7o7KYbcNQqodbNPDGTi\" rel=\"nofollow\" target=\"_blank\" title=\"@NxeraPharma\">@NxeraPharma<\/a> | X: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lRxeCMXPo7q5nGEjaAnntWxe_ANajkNrywDCKFP-ZMBdJT8C7YuXRsS7KEGd-jdKyF-kqv2zHa3XAjBrVvJyy5LK-0GYRJ7cXZF_-ZnmReo=\" rel=\"nofollow\" target=\"_blank\" title=\"@NxeraPharma\">@NxeraPharma<\/a> | YouTube: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lRxeCMXPo7q5nGEjaAnntfESC5yl29Z-aBhn4Gf_uyL-JBd-f-l1HrK3BmY1UkKcYmPu0JiemSgEXfZnHJkgxBtGCuk8q0pIZ6J4zBuvJVw=\" rel=\"nofollow\" target=\"_blank\" title=\"@NxeraPharma\">@NxeraPharma<\/a><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><b>Enquiries:<\/b><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><b>Nxera \u2013 Media and Investor Relations<\/b><br \/>Shinya Tsuzuki, VP, Head of Investor Relations<br \/>+81 (0)3 5962 5718 | +44 (0)1223 949390 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A5u7jb3XjvJwfJQH0SFaNE-yHOq6lYWQ9fn8k8ZlqrxepToaZ17ZK8dgHJbHYskd5EhWh8m39Lhqp0QFH-u6T0RT3W_eKCus9-8OW-Nfqos=\" rel=\"nofollow\" target=\"_blank\" title=\"|IR@Nxera.life\">|IR@Nxera.life<\/a><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><b>MEDiSTRAVA (for International Media)<\/b><br \/>Mark Swallow, Frazer Hall, Erica Hollingsworth<br \/>+44 (0)203 928 6900 | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QpA5TF-LZLCkG0t2SlwvgzYjGBLZu-mZx6ZLmtrxsHeouDCIlXdYcLhSHP46qKihkVGjJmpfr_djUiohEe0MgB-_vZnKuYFaGCIwiahTLes=\" rel=\"nofollow\" target=\"_blank\" title=\"Nxera@medistrava.com\">Nxera@medistrava.com<\/a><\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><b>Forward-looking statements<\/b><br \/>This press release contains forward-looking statements, including statements about the discovery, development, and commercialization of products. Various risks may cause Nxera Pharma Group\u2019s actual results to differ materially from those expressed or implied by the forward looking statements, including: adverse results in clinical development programs; failure to obtain patent protection for inventions; commercial limitations imposed by patents owned or controlled by third parties; dependence upon strategic alliance partners to develop and commercialize products and services; difficulties or delays in obtaining regulatory approvals to market products and services resulting from development efforts; the requirement for substantial funding to conduct research and development and to expand commercialization activities; and product initiatives by competitors. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"no-referrer-when-downgrade\"\/>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tokyo, Japan and Cambridge, UK, 9 November 2026 \u2013 Nxera Pharma Co., Ltd. (\u201cNxera\u201d or \u201cthe Company\u201d; TSE 4565) announces its President &amp; CEO, Chris Cargill, will participate in a \u2018Fireside Chat\u2019 at the Jefferies London Healthcare Conference on Monday,16th November at 4:30 p.m. GMT \/ 17th 1:30 a.m. JST. During the event, Mr. Cargill [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":434726,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/5cc74d52-c86f-4e21-8684-3496281fee15","fifu_image_alt":"","footnotes":""},"categories":[57166],"tags":[],"class_list":["post-434725","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"_links":{"self":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/434725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/comments?post=434725"}],"version-history":[{"count":0,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/434725\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/media\/434726"}],"wp:attachment":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/media?parent=434725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/categories?post=434725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/tags?post=434725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}